Seeking Alpha EN

Globus Medical raises 2026 EPS guidance to $4.40-$4.50 with margin gains following record Q4 results

Feb 25, 2026 &02082525202628; 03:08 UTC seekingalpha.com Trending 4/5

Read original on seekingalpha.com ↗

↗

Positive for markets

Sentiment score: +80/100

High impact Medium-term (weeks)

WHAT THIS MEANS

Globus Medical ha aumentato la guida EPS per il 2026 a $4,40-$4,50 grazie a guadagni di margine dopo i risultati record del Q4.

AI CONFIDENCE

85% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

GMED

GMEDStock

Expected to rise

Aumento della guida EPS e guadagni di margine

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

I trader potrebbero considerare di acquistare GMED, considerando l'aumento della guida EPS e i guadagni di margine.

KEY SIGNALS

Aumento della guida EPSGuadagni di margine

SECTORS INVOLVED

Salute e Benessere

Analysis generated on Feb 25, 2026 at 03:17 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Globus Medical raises 2026 EPS guidance to $4.40-$4.50 with margin gains following record Q4 results

RELATED INTELLIGENCE